News

5 Indian hospitals to conduct WHO's Solidarity COVID-19 clinical trial of Remdesivir & other drugs

The hospitals will perform clinical trials on at least 1,500 patients the newly repurposed drug such as Remdeisvir that US FDA has given conditional approval last week.

May 11, 2020

By : Team ABLE

Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies for COVID-19 therapy

 The Council of Scientific and Industrial Research (CSIR) has sanctioned development of human monoclonal antibodies as therapy for COVID-19 infections.

May 08, 2020

By : Team ABLE

Lab-grown mini human organs to accelerate COVID-19 drug development research

In these human organ-like structures, scientists are beginning to perform more experiments to explore how the SARS-CoV-2 virus replicates in hosts, or even test vaccines and drugs against COVID-19.

May 08, 2020

By : TeamABLE

CSIR contributes 53 entries to global Coronavirus genome database

CSIR has submitted as many as 53 genome sequences of the novel coronavirus (COVID-19) to a global genome database.

May 08, 2020

By : Team ABLE

DBT seeks Letters of Intent from scientists for setting up Cancer Virtual Network Centers

DBT has invited Letters of Intent (LoI) in the area of Cancer Immunology & Immunotherapy from eligible scientists and clinicians for setting-up of Virtual Network Centers (VNCs) for a period of five years.

May 08, 2020

By : Team ABLE